CD44 also regulates intracellular signaling pathways, such as PI3K/AKT, MAPK/ERK, and NF‐κB. CD44 is expressed in various normal tissues and cells, but its expression is altered in many cancers. This evidence concerns the gene NFKB1 and cancer.